78 research outputs found
Correction to Catalytic Enantioselective Desymmetrization of 1,3-Diazido-2-propanol via Intramolecular Interception of Alkyl Azides with Diazo(aryl)acetates
Correction to Catalytic Enantioselective Desymmetrization
of 1,3-Diazido-2-propanol via Intramolecular Interception of Alkyl
Azides with Diazo(aryl)acetate
Catalytic Enantioselective Desymmetrization of 1,3-Diazido-2-propanol via Intramolecular Interception of Alkyl Azides with Diazo(aryl)acetates
The
first catalytic enantioselective desymmetrization of 1,3-diazido-2-propanol
via an intramolecular interception of alkyl azides by Cu–carbenoids
has been realized. A wide range of 1,3-diazidoisopropyl diazo(aryl)acetates
were converted to cyclic α-imino esters in the presence of bisoxazoline
ligand (<i>S,S</i>)-Ph-Box with good to excellent yields,
and the enantiomeric excess was up to 97%
Catalytic Enantioselective Desymmetrization of 1,3-Diazido-2-propanol via Intramolecular Interception of Alkyl Azides with Diazo(aryl)acetates
The
first catalytic enantioselective desymmetrization of 1,3-diazido-2-propanol
via an intramolecular interception of alkyl azides by Cu–carbenoids
has been realized. A wide range of 1,3-diazidoisopropyl diazo(aryl)acetates
were converted to cyclic α-imino esters in the presence of bisoxazoline
ligand (<i>S,S</i>)-Ph-Box with good to excellent yields,
and the enantiomeric excess was up to 97%
Catalytic Enantioselective Desymmetrization of 1,3-Diazido-2-propanol via Intramolecular Interception of Alkyl Azides with Diazo(aryl)acetates
The
first catalytic enantioselective desymmetrization of 1,3-diazido-2-propanol
via an intramolecular interception of alkyl azides by Cu–carbenoids
has been realized. A wide range of 1,3-diazidoisopropyl diazo(aryl)acetates
were converted to cyclic α-imino esters in the presence of bisoxazoline
ligand (<i>S,S</i>)-Ph-Box with good to excellent yields,
and the enantiomeric excess was up to 97%
Formation of <i>S</i>‑[2‑(<i>N</i><sup>6</sup>‑Deoxyadenosinyl)ethyl]glutathione in DNA and Replication Past the Adduct by Translesion DNA Polymerases
1,2-Dibromoethane
(DBE, ethylene dibromide) is a potent carcinogen
due at least in part to its DNA cross-linking effects. DBE cross-links
glutathione (GSH) to DNA, notably to sites on 2′-deoxyadenosine
and 2′-deoxyguanosine (Cmarik, J. L., et al. (1991) J. Biol. Chem. 267, 6672−6679). Adduction at the N6 position of 2′-deoxyadenosine
(dA) had not been detected, but this is a site for the linkage of <i>O</i><sup>6</sup>-alkylguanine DNA alkyltransferase (Chowdhury, G., et al. (2013) Angew. Chem. Int. Ed. 52, 12879−12882). We identified
and quantified a new adduct, <i>S</i>-[2-(<i>N</i><sup>6</sup>-deoxyadenosinyl)ethyl]GSH, in calf thymus DNA using
LC-MS/MS. Replication studies were performed in duplex oligonucleotides
containing this adduct with human DNA polymerases (hPols) η,
ι, and κ, as well as with <i>Sulfolobus solfataricus</i> Dpo4, <i>Escherichia coli</i> polymerase I Klenow fragment,
and bacteriophage T7 polymerase. hPols η and ι, Dpo4,
and Klenow fragment were able to bypass the adduct with only slight
impedance; hPol η and ι showed increased misincorporation
opposite the adduct compared to that of unmodified 2′-deoxyadenosine.
LC-MS/MS analysis of full-length primer extension products by hPol
η confirmed the incorporation of dC opposite <i>S</i>-[2-(<i>N</i><sup>6</sup>-deoxyadenosinyl)ethyl]GSH and
also showed the production of a −1 frameshift. These results
reveal the significance of <i>N</i><sup>6</sup>-dA GSH-DBE
adducts in blocking replication, as well as producing mutations, by
human translesion synthesis DNA polymerases
La tierra : bosquejos de la vida rural
A designed
Tf<sub>2</sub>O-promoted intramolecular Schmidt reaction
of 2-substituted ω-azido carboxylic acids was demonstrated.
Tf<sub>2</sub>O was used as an activation reagent for the carboxylic
acid, and ω-azido anhydride was in situ generated, releasing
a molecular TfOH, which acted as an acid promoter for the Schmidt
process. A series of 2-substituted pyrrolidines was produced and acetylated
for better purification. The strategy was also efficient for conversion
of a 4-substituted ω-azido carboxylic acid to the tricyclic
lactam
Iridium(III)-Based PD-L1 Agonist Regulates p62 and ATF3 for Enhanced Cancer Immunotherapy
Anti-PD-L1
immunotherapy, a new lung cancer treatment,
is limited
to a few patients due to low PD-L1 expression and tumor immunosuppression.
To address these challenges, the upregulation of PD-L1 has the potential
to elevate the response rate and efficiency of anti-PD-L1 and alleviate
the immunosuppression of the tumor microenvironment. Herein, we developed
a novel usnic acid-derived Iridium(III) complex, Ir-UA, that boosts PD-L1 expression and converts “cold tumors”
to “hot”. Subsequently, we administered Ir-UA combined with anti-PD-L1 in mice, which effectively inhibited tumor
growth and promoted CD4+ and CD8+ T cell infiltration.
To our knowledge, Ir-UA is the first iridium-based complex
to stimulate the expression of PD-L1 by explicitly regulating its
transcription factors, which not only provides a promising platform
for immune checkpoint blockade but, more importantly, provides an
effective treatment strategy for patients with low PD-L1 expression
Iridium(III)-Based PD-L1 Agonist Regulates p62 and ATF3 for Enhanced Cancer Immunotherapy
Anti-PD-L1
immunotherapy, a new lung cancer treatment,
is limited
to a few patients due to low PD-L1 expression and tumor immunosuppression.
To address these challenges, the upregulation of PD-L1 has the potential
to elevate the response rate and efficiency of anti-PD-L1 and alleviate
the immunosuppression of the tumor microenvironment. Herein, we developed
a novel usnic acid-derived Iridium(III) complex, Ir-UA, that boosts PD-L1 expression and converts “cold tumors”
to “hot”. Subsequently, we administered Ir-UA combined with anti-PD-L1 in mice, which effectively inhibited tumor
growth and promoted CD4+ and CD8+ T cell infiltration.
To our knowledge, Ir-UA is the first iridium-based complex
to stimulate the expression of PD-L1 by explicitly regulating its
transcription factors, which not only provides a promising platform
for immune checkpoint blockade but, more importantly, provides an
effective treatment strategy for patients with low PD-L1 expression
Preparation of Optically Active <i>cis</i>-Cyclopropane Carboxylates: Cyclopropanation of α‑Silyl Stryenes with Aryldiazoacetates and Desilylation of the Resulting Silyl Cyclopropanes
Optically
active <i>cis</i>-cyclopropane carboxylates
are prepared via the Rh<sub>2</sub>(<i>S</i>-PTAD)<sub>4</sub>-catalyzed cyclopropanation of α-silyl styrenes with aryl diazoacetates
followed by desilylation of the resulting silyl cyclopropane carboxylates.
The conjugation of the aryl ring with CC bond and π
stacking are proposed for the stereoselectivity of cyclopropanation,
and configuration inversion is observed with the desilylation process
Mass Spectrometric Identification of Water-Soluble Gold Nanocluster Fractions from Sequential Size-Selective Precipitation
This paper presents a simple and convenient methodology
to separate and characterize water-soluble gold nanocluster stabilized
with penicillamine ligands (AuNC-SR) in aqueous medium by sequential
size-selective precipitation (SSSP) and mass spectrometry (MS). The
highly polydisperse crude AuNC-SR product with an average core diameter
of 2.1 nm was initially synthesized by a one-phase solution method.
AuNCs were then precipitated and separated successively from larger
to smaller ones by progressively increasing the concentration of acetone
in the aqueous AuNCs solution. The SSSP fractions were analyzed by
UV–vis spectroscopy, matrix-assisted laser desorption/ionization
time-of-flight-MS, and thermogravimetric analysis (TGA). The MS and
TGA data confirmed that the fractions precipitated from 36, 54, 72,
and 90% v/v acetone (<i>F</i><sub>36%</sub>, <i>F</i><sub>54%</sub>, <i>F</i><sub>72%</sub>, and <i>F</i><sub>90%</sub>) comprised families of close core size AuNCs with
average molecular formulas of Au<sub>38</sub>(SR)<sub>18</sub>, Au<sub>28</sub>(SR)<sub>15</sub>, Au<sub>18</sub>(SR)<sub>12</sub>, and
Au<sub>11</sub>(SR)<sub>8</sub>, respectively. In addition, <i>F</i><sub>36%</sub>, <i>F</i><sub>54%</sub>, <i>F</i><sub>72%</sub>, and <i>F</i><sub>90%</sub> contained
also the typical magic-sized gold nanoparticles of Au<sub>38</sub>, Au<sub>25</sub>, Au<sub>18</sub>, and Au<sub>11</sub>, respectively,
together with some other AuNCs. This study shed light on the potential
use of SSSP for simple and large-scale preliminary separation of polydisperse
water-soluble AuNCs into different fractions with a relatively narrower
size distribution
- …